Statistics

Total Visits

Views
Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel13

Select a period of time:

Number of views in the range

Views
Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel6

Views

Views
May 20240
June 20241
July 20241
August 20241
September 20243
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Chicago1